Oxybutynin reports

Abdominal Discomfort while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and abdominal discomfort appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Abdominal Pain Upper while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and abdominal pain upper appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Abdominal Pain while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and abdominal pain appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Acid reflux while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and acid reflux appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Alopecia while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and alopecia appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Anxiety while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and anxiety appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Application Site Pain while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and application site pain appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Application Site Rash while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and application site rash appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Application-site itching while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and application-site itching appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Application-site redness while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and application-site redness appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Back Pain while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and back pain appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Burning Sensation while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and burning sensation appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Constipation while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and constipation appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Cough while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and cough appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Decreased Appetite while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and decreased appetite appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Dehydration while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and dehydration appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Diarrhea while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and diarrhea appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Dizziness while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and dizziness appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Dry Mouth while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and dry mouth appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Dyspepsia while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and dyspepsia appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Fatigue while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and fatigue appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Feeling Abnormal while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and feeling abnormal appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Headache while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and headache appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Hypotension while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and hypotension appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Insomnia while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and insomnia appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Itching while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and itching appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Malaise while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and malaise appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Muscle Spasms while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and muscle spasms appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Muscular Weakness while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and muscular weakness appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Myalgia while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and myalgia appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Nausea while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and nausea appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Pain while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and pain appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Peripheral swelling while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and peripheral swelling appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Rash while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and rash appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Shortness of breath while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and shortness of breath appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Skin redness while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and skin redness appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Sleepiness while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and sleepiness appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Tingling or pins and needles while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and tingling or pins and needles appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Tremor while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and tremor appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Vision Blurred while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and vision blurred appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Vomiting while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and vomiting appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Weakness while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and weakness appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Weight Decreased while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and weight decreased appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Weight Increased while using Oxybutynin

FDA FAERS contains adverse-event reports in which Oxybutynin and weight increased appear together. This does not establish that Oxybutynin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →